Skip to main content

Biofrontera Inc.

For the period ended Jun 30, 2026. Filed Aug 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 13, 2026

BFRI$0.83+2.5%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30,2026

OR

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission file number 001-40943

Biofrontera Inc.

(Exact name of registrant as specified in its charter)

Delaware47-3765675
(State or other jurisdiction of incorporation or organization)(IRS Employer Identification No.)
660 Main Street, 1st Floor, Woburn, Massachusetts01801
(Address of principal executive offices)(Zip Code)

(781) 245-1325

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.001 per shareBFRIThe Nasdaq Stock Market LLC
Warrants to purchase common stockBFRIWThe Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☐Accelerated filer☐
Non-accelerated filer☒Smaller reporting company☒
Emerging growth company☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No☒

As of August 11, 2026, there were 14,852,359 shares outstanding of the registrant’s common stock, par value $0.001 per share.

TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
ITEM 1.Financial Statements3
Condensed Consolidated Balance Sheets as of June 30, 2026 (unaudited) and December 31, 20253
Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026 (unaudited) and 2025 (unaudited)4
Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2026 (unaudited) and 2025 (unaudited)5
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2026 (unaudited) and 2025 (unaudited)6
Notes to Condensed Consolidated Financial Statements7
ITEM 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations23
ITEM 3.Quantitative and Qualitative Disclosures About Market Risk35
ITEM 4.Controls and Procedures35
PART II. OTHER INFORMATION
ITEM 1.Legal Proceedings36
ITEM 1A.Risk Factors36
ITEM 2.Unregistered Sales of Equity Securities and Use of Proceeds36
ITEM 3.Defaults Upon Senior Securities36
ITEM 4.Mine Safety Disclosures36
ITEM 5.Other Information36
ITEM 6.Exhibits36
Signatures37
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.